146 related articles for article (PubMed ID: 10488246)
21. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents?
Supuran CT; Briganti F; Tilli S; Chegwidden WR; Scozzafava A
Bioorg Med Chem; 2001 Mar; 9(3):703-14. PubMed ID: 11310605
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
[TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX.
Casey JR; Morgan PE; Vullo D; Scozzafava A; Mastrolorenzo A; Supuran CT
J Med Chem; 2004 Apr; 47(9):2337-47. PubMed ID: 15084132
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.
Renzi G; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2000 Apr; 10(7):673-6. PubMed ID: 10762051
[TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
[TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
33. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
Scozzafava A; Briganti F; Mincione G; Menabuoni L; Mincione F; Supuran CT
J Med Chem; 1999 Sep; 42(18):3690-700. PubMed ID: 10479300
[TBL] [Abstract][Full Text] [Related]
34. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.
Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase inhibitors - part 78(#). Synthesis of water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intraocular pressure lowering properties via the topical route.
Supuran CT; Briganti F; Menabuoni L; Mincione G; Mincione F; Scozzafava A
Eur J Med Chem; 2000 Mar; 35(3):309-21. PubMed ID: 10785557
[TBL] [Abstract][Full Text] [Related]
36. (R)-/(S)-10-camphorsulfonyl-substituted aromatic/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases.
Maresca A; Supuran CT
Bioorg Med Chem Lett; 2011 Mar; 21(5):1334-7. PubMed ID: 21300547
[TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
[TBL] [Abstract][Full Text] [Related]
38. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
39. Carbonic anhydrase inhibitors: design of membrane-impermeant copper(II) complexes of DTPA-, DOTA-, and TETA-tailed sulfonamides targeting the tumor-associated transmembrane isoform IX.
Rami M; Cecchi A; Montero JL; Innocenti A; Vullo D; Scozzafava A; Winum JY; Supuran CT
ChemMedChem; 2008 Nov; 3(11):1780-8. PubMed ID: 18956406
[TBL] [Abstract][Full Text] [Related]
40. New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.
Esteves MA; Ortet O; Capelo A; Supuran CT; Marques SM; Santos MA
Bioorg Med Chem Lett; 2010 Jun; 20(12):3623-7. PubMed ID: 20478708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
